Innovating Works

LIFETEC GROUP

Desconocido
SAFE-CAB: Laser Assisted Surgical System to Revolutionize Cardiac Bypass Surgeries LIFETEC GROUP BV participó en un H2020: H2020-EIC-FTI-2018-2020 Coronary Artery Bypass (CAB) surgery is performed annually in >700,000 patients to treat coronary artery disease and prevent myocardial infa...
2019-10-10 - 2023-06-30 | Financiado
PLS: Perinatal Life Support System Integration of Enabling Technologies for Clinical Translation LIFETEC GROUP BV participó en un H2020: H2020-FETOPEN-2018-2020 Every year, 800.000 babies are born extremely preterm (EP; <28 weeks of age) worldwide. A large proportion of survivors from this group of s...
2019-09-24 - 2024-09-30 | Financiado
SINERGIA: advanced technologieS for drug dIscovery and precisioN mEdicine in vitRo modellinG human physiology... LIFETEC GROUP BV participó en un H2020: H2020-MSCA-ITN-2019 A key step in the drug development process is to predict information on safety, efficacy and mechanisms of action of a candidate molecule as...
2019-08-09 - 2024-02-29 | Financiado
CarBon: Controlling Cartilage to Bone Transitions for Improved Treatment of Bone Defects and Osteoarthritis LIFETEC GROUP BV participó en un H2020: H2020-MSCA-ITN-2016 A well-functioning locomotor system is essential for human well-being. This is an important consideration in our aging population with the i...
2016-08-25 - 2020-12-31 | Financiado
CompBioMed: A Centre of Excellence in Computational Biomedicine LIFETEC GROUP BV participó en un H2020: H2020-EINFRA-2014-2015 This Centre of Excellence will advance the role of computationally based modelling and simulation within biomedicine. Three related user com...
2016-06-03 - 2019-09-30 | Financiado
VPH-CaSE: VPH Cardiovascular Simulation and Experimentation for Personalised Medical Devices LIFETEC GROUP BV participó en un H2020: H2020-MSCA-ITN-2014 VPH-CaSE is focused on state-of-the-art developments in personalised cardiovascular support, underpinned by simulation and experimentation,...
2014-12-16 - 2018-12-31 | Financiado
MUSICARE: MUltiSectoral Integrative approaches to CArdiac care LIFETEC GROUP BV participó en un H2020: H2020-MSCA-ITN-2014 MUltiSectoral Integrative approaches to CArdiac care – MUSICARE - is proposed by a team of universities, companies and hospitals from 4 EU c...
2014-12-16 - 2018-12-31 | Financiado
BIOGEL: Engineering responsive and biomimetic hydrogels for biomedical therapeutic and diagnostic applicatio... LIFETEC GROUP BV participó en un H2020: H2020-MSCA-ITN-2014 BIOGEL is set up to educate young scientists to develop innovative hydrogel chemistries and systems for biomedical applications. The first o...
2014-12-09 - 2018-12-31 | Financiado
BIP-UPY: Bioactive Implantable Polymers based on UreidoPyrimidinone LIFETEC GROUP BV participó en un FP7: BIP-UPy addresses the need for biomedical implants which can be easily fine-tuned in their properties in regards to bioactivity, biodegradab...
Financiado
euHeart: Personalised and intergrated cardiac care nPatient specific Cardiovascular Modelling and Simulatio... Cardiovascular disease (CVD) has a significant impact on the European society in terms of mortality, morbidity and allied healthcare costs....
Financiado
HYDROZONES: Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration LIFETEC GROUP BV participó en un FP7: Degeneration of cartilage is a major cause of chronic pain, lost mobility and reduced quality of life for millions of European citizens. Fro...
Financiado
SMARTER: Small Artery Remodelling LIFETEC GROUP BV participó en un FP7: Cardiovascular disease remains a major cause of morbidity and mortality in Europe. Small arteries form a key element in the pathogenesis. Th...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.